Microfluidic Systems awarded series of patents

Published: 28-May-2010

Covering automated airborne pathogen identification system


Microfluidic Systems (MFSI) has been awarded a series of new patents covering the components and integrated systems that perform fully automated sample collection through identification of airborne pathogens such as bacteria, viruses, and toxins.

Patent 7,705,739, Integrated Airborne Substance Collection and Detection System, covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system. The system, which includes a sample collection, biological triggering system, sample processing, amplification, and organism identification, as well as toxin protein detection, provides for both an early warning system with a specific confirmatory system.

Within the automated integrated system are key components and methodologies that MFSI has also patented. For example, patent 7,699,915, Liquid Impingement Unit optimises the process of injecting an airborne sample into a liquid-based pathogen processing and detection system.

“With these additional patents and our on-going programme to build and test these automated systems, we are well on the way to implementing a key solution to airborne pathogen monitoring,” said Allen Northrup, Microfluidic Systems’ founder and ceo.

MFSI develops microfluidic systems for the automated preparation of and performance of biological assays.

You may also like